Literature DB >> 22319019

Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors.

Michael T Milano1, Carl R Peterson, Hong Zhang, Deepinder P Singh, Yuhchyau Chen.   

Abstract

BACKGROUND: Patients with head and neck squamous cell cancer (HNSCC) are at risk of developing second primary lung cancer (SPLC).
METHODS: Among 61,883 patients with HNSCC from the Surveillance, Epidemiology and End Results (SEER) database, 4522 developed SPLC (any histology) ≥2 months after HNSCC. We correlated risk with demographic and tumor-related parameters.
RESULTS: The risk of SPLC after HNSCC was 5.8%, 11.4%, and 16.4% at 5, 10, and 15 years, respectively. From Cox regression, significantly adverse (p < .0001) risk factors for SPLC included: regional versus localized HNSCC stage (hazard ratio [HR] = 1.16), hypopharyngeal or supraglottic laryngeal site (HR = 1.57), increased age (HR = 1.26/decade), black race (HR = 1.27), and male sex (HR = 1.26). Glottic (HR = 0.75) and tonsillar or oral cavity sites (HR = 0.80) were associated with significantly (p < .0001) lower risks of SPLC.
CONCLUSION: From population-based actuarial analyses, HNSCCs with more aggressive clinicopathologic features were more apt to develop SPLC, suggestive of similar environmental and/or host factors for these cancers.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22319019     DOI: 10.1002/hed.22006

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?

Authors:  Geena X Wu; Rebecca A Nelson; Jae Y Kim; Dan J Raz
Journal:  Clin Lung Cancer       Date:  2017-03-02       Impact factor: 4.785

2.  Effects of Anesthetic Technique on Postoperative Pulmonary Metastasis in Patients Undergoing Laryngectomy.

Authors:  Xuan-Wei Huang; Xu-Dong Wang; Jie-Lan Lai; Ya-Li Lu; Kun Deng; Ren-Chun Lai
Journal:  Cancer Manag Res       Date:  2020-07-07       Impact factor: 3.989

3.  Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?

Authors:  Elisabeth O'Dwyer; Darragh F Halpenny; Michelle S Ginsberg
Journal:  Eur Radiol       Date:  2020-07-29       Impact factor: 5.315

4.  Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.

Authors:  Shan Shan; Jun She; Zhi-Qiang Xue; Chun-Xia Su; Shen-Xiang Ren; Feng-Ying Wu
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

5.  Clonality analysis of pulmonary tumors by genome-wide copy number profiling.

Authors:  Julien P L Vincenten; Hendrik F van Essen; Birgit I Lissenberg-Witte; Nicole W J Bulkmans; Oscar Krijgsman; Daoud Sie; Paul P Eijk; Egbert F Smit; Bauke Ylstra; Erik Thunnissen
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

6.  African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.

Authors:  Yusra F Shao; Seongho Kim; John D Cramer; Dina Farhat; Jeffrey Hotaling; Syed Naweed Raza; George Yoo; Ho-Sheng Lin; Harold Kim; Ammar Sukari; Misako Nagasaka
Journal:  Head Neck       Date:  2022-06-17       Impact factor: 3.821

Review 7.  Lung nodules: A comprehensive review on current approach and management.

Authors:  Konstantinos Loverdos; Andreas Fotiadis; Chrysoula Kontogianni; Marianthi Iliopoulou; Mina Gaga
Journal:  Ann Thorac Med       Date:  2019 Oct-Dec       Impact factor: 2.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.